Bladder Cancer Coverage from Every Angle

Monika Joshi, MD, on After the DUART Trial: Next Steps in Treating Urothelial Cancer of the Bladder

Posted: Monday, February 22, 2021

Monika Joshi, MD, of Penn State Hershey Cancer Institute, discusses possible next treatment steps in light of findings from the DUART study on concurrent durvalumab and radiation therapy followed by adjuvant durvalumab in patients with localized urothelial cancer of the bladder. Dr. Joshi also offers advice on managing adverse effects to clinicians with little experience using this checkpoint inhibitor.

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.